Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Medpace Hldgs Raises FY2025 GAAP EPS Guidance from $13.76-$14.53 to $14.60-$14.86 vs $14.07 Est; Raises FY2025 Sales Guidance from $2.420B-$2.520B to $2.480B-$2.530B vs $2.464B Est

Author: Benzinga Newsdesk | October 22, 2025 03:16pm
Medpace Hldgs (NASDAQ:MEDP) raises FY2025 GAAP EPS guidance from $13.76-$14.53 to $14.60-$14.86 vs $14.07 analyst estimate. Raises FY2025 sales outlook from $2.420 billion-$2.520 billion to $2.480 billion-$2.530 billion vs $2.464 billion estimate.

Posted In: MEDP


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist